How Analysts Feel About XOMA Corporation (XOMA) After Today’s Big Increase?

September 17, 2017 - By Henry Gaston

The stock of XOMA Corporation (NASDAQ:XOMA) is a huge mover today! The stock increased 3.63% or $0.68 on September 15, reaching $19.4. About 308,253 shares traded or 14.35% up from the average. XOMA Corporation (NASDAQ:XOMA) has declined 51.66% since September 17, 2016 and is downtrending. It has underperformed by 68.36% the S&P500.
The move comes after 7 months positive chart setup for the $147.40M company. It was reported on Sep, 17 by Barchart.com. We have $20.37 PT which if reached, will make NASDAQ:XOMA worth $7.37 million more.

Investors wait XOMA Corporation (NASDAQ:XOMA) to report on November, 8. its quarterly earnings Wall Street analysts expect $-0.81 EPS, up $1.32 or 61.97 % from last year’s $-2.13 same quarter earnings. XOMA Corporation’s Wall Street analysts see -485.71 % negative EPS growth, taking into account the $0.21 EPS reproted in the previous quarter,

XOMA Corporation (NASDAQ:XOMA) Ratings Coverage

Among 6 analysts covering Xoma Limited (NASDAQ:XOMA), 2 have Buy rating, 0 Sell and 4 Hold. Therefore 33% are positive. Xoma Limited had 14 analyst reports since July 23, 2015 according to SRatingsIntel. As per Monday, November 14, the company rating was downgraded by Wedbush. The rating was upgraded by Wedbush on Tuesday, September 5 to “Outperform”. The stock has “Buy” rating by Zacks on Friday, August 28. On Monday, August 14 the stock rating was maintained by Wedbush with “Hold”. On Thursday, August 10 the stock rating was maintained by H.C. Wainwright with “Buy”. The company was maintained on Monday, March 27 by Wedbush. As per Wednesday, July 22, the company rating was downgraded by Ladenburg Thalmann. On Wednesday, July 22 the stock rating was downgraded by Piper Jaffray to “Neutral”. The rating was downgraded by Jefferies to “Hold” on Thursday, July 23. The rating was downgraded by Zacks to “Hold” on Friday, September 4.

More important recent XOMA Corporation (NASDAQ:XOMA) news were published by: Seekingalpha.com which released: “Xoma Just Saved Itself Again” on August 28, 2017, also Globenewswire.com published article titled: “XOMA Announces Transformational License Agreements for Gevokizumab and its IL …”, Globenewswire.com published: “XOMA Earns $3 Million Milestone Payment from its License Agreement with …” on September 11, 2017. More interesting news about XOMA Corporation (NASDAQ:XOMA) was released by: Seekingalpha.com and their article: “XOMA Out-License Model Catching Waves” with publication date: September 13, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.